{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T11:40:07Z","timestamp":1755776407300,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["cstc2021jcyj-msxmX0327"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0327"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022502078"],"award-info":[{"award-number":["2022502078"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04311-x","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:36:30Z","timestamp":1749555390000},"page":"704-709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Normotensive primary aldosteronism in a patient with myasthenia gravis: a localization diagnostic conundrum unraveled by 68Ga-pentixafor PET\/CT - a case report with review of literature"],"prefix":"10.1007","volume":"89","author":[{"given":"Jin-Liang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Xiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shriya","family":"Sanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"4311_CR1","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"M. Reincke, I. Bancos, P. Mulatero et al., Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 9, 876\u2013892 (2021). https:\/\/doi.org\/10.1016\/S2213-8587(21)00210-2.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4311_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero et al., The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4311_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"T.A. Williams, J.W.M. Lenders, P. Mulatero et al., Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 5, 689\u2013699 (2017). https:\/\/doi.org\/10.1016\/S2213-8587(17)30135-3.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4311_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S2213-8587(24)00308-5","volume":"13","author":"J Yang","year":"2025","unstructured":"J. Yang, J. Burrello, J. Goi et al., Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort. Lancet Diabetes Endocrinol. 13, 119\u2013133 (2025). https:\/\/doi.org\/10.1016\/S2213-8587(24)00308-5.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4311_CR5","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Z. Xu, J. Yang, J. Hu et al., Primary aldosteronism in patients in china with recently detected hypertension. J. Am. Coll. Cardiol. 75, 1913\u20131922 (2020). https:\/\/doi.org\/10.1016\/j.jacc.2020.02.052.","journal-title":"J. Am. Coll. Cardiol."},{"key":"4311_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"J.M. Brown, M. Siddiqui, D.A. Calhoun et al., The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann. Intern. Med. 173, 10\u201320 (2020). https:\/\/doi.org\/10.7326\/M20-0065.","journal-title":"Ann. Intern. Med."},{"key":"4311_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12149-023-01851-y","volume":"37","author":"X Ren","year":"2023","unstructured":"X. Ren, G. Cheng, Z. Wang, Advances in the molecular imaging of primary aldosteronism. Ann. Nucl. Med. 37, 433\u2013441 (2023). https:\/\/doi.org\/10.1007\/s12149-023-01851-y.","journal-title":"Ann. Nucl. Med."},{"key":"4311_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"B. Heinze, C.T. Fuss, P. Mulatero et al., Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension 71, 317\u2013325 (2018). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09975.","journal-title":"Hypertension"},{"key":"4311_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1291775","volume":"15","author":"X Yin","year":"2024","unstructured":"X. Yin, K. Ai, J. Luo et al., A comparison of the performance of 68Ga-Pentixafor PET\/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism. Front. Endocrinol. 15, 1291775 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1291775.","journal-title":"Front. Endocrinol."},{"key":"4311_CR10","doi-asserted-by":"publisher","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"J. Hu, T. Xu, H. Shen et al., Accuracy of Gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw. Open 6, e2255609 (2023). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55609.","journal-title":"JAMA Netw. Open"},{"key":"4311_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7326\/M17-0882","volume":"167","author":"JM Brown","year":"2017","unstructured":"J.M. Brown, C. Robinson-Cohen, M.A. Luque-Fernandez et al., The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study. Ann. Intern. Med. 167, 630\u2013641 (2017). https:\/\/doi.org\/10.7326\/M17-0882.","journal-title":"Ann. Intern. Med."},{"key":"4311_CR12","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","volume":"105","author":"A Vaidya","year":"2020","unstructured":"A. Vaidya, R.M. Carey, Evolution of the primary aldosteronism syndrome: updating the approach. J. Clin. Endocrinol. Metab. 105, 3771\u20133783 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa606.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4311_CR13","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"P. Mulatero, S. Monticone, J. Deinum et al., Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J. Hypertens. 38, 1919\u20131928 (2020). https:\/\/doi.org\/10.1097\/HJH.0000000000002510.","journal-title":"J. Hypertens."},{"key":"4311_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.124.24153","volume":"82","author":"JM Brown","year":"2025","unstructured":"J.M. Brown, B. Honzel, L.C. Tsai et al., Characterizing the origins of primary aldosteronism. Hypertension 82, 306\u2013318 (2025). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.124.24153.","journal-title":"Hypertension"},{"key":"4311_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11886-021-01538-8","volume":"23","author":"T Wannachalee","year":"2021","unstructured":"T. Wannachalee, A.F. Turcu, Primary aldosteronism: a continuum from normotension to hypertension. Curr. Cardiol. Rep. 23, 105 (2021). https:\/\/doi.org\/10.1007\/s11886-021-01538-8.","journal-title":"Curr. Cardiol. Rep."},{"key":"4311_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","volume":"149","author":"GL Hundemer","year":"2024","unstructured":"G.L. Hundemer, M. Agharazii, F. Madore et al., Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study. Circulation 149, 124\u2013134 (2024). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066389.","journal-title":"Circulation"},{"key":"4311_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti et al., Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6, 41\u201350 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4311_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/ijms18040848","volume":"18","author":"F Buffolo","year":"2017","unstructured":"F. Buffolo, S. Monticone, T.A. Williams et al., Subtype diagnosis of primary aldosteronism: is adrenal vein sampling always necessary?. Int. J. Mol. Sci. 18, 848 (2017). https:\/\/doi.org\/10.3390\/ijms18040848.","journal-title":"Int. J. Mol. Sci."},{"key":"4311_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"G.P. Rossi, R.J. Auchus, M. Brown et al., An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 63, 151\u2013160 (2014). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02097.","journal-title":"Hypertension"},{"key":"4311_CR20","doi-asserted-by":"publisher","first-page":"150075","DOI":"10.1530\/EDM-15-0075","volume":"2015","author":"R Goupil","year":"2015","unstructured":"R. Goupil, M. Wolley, J. Ungerer et al., Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion. Endocrinol. Diabetes Metab. Case Rep. 2015, 150075 (2015). https:\/\/doi.org\/10.1530\/EDM-15-0075.","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"4311_CR21","doi-asserted-by":"publisher","first-page":"e720","DOI":"10.1210\/clinem\/dgad179","volume":"108","author":"F Buffolo","year":"2023","unstructured":"F. Buffolo, J. Pieroni, F. Ponzetto et al., Prevalence of cortisol cosecretion in patients with primary aldosteronism: role of metanephrine in adrenal vein sampling. J. Clin. Endocrinol. Metab. 108, e720\u2013e725 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad179.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4311_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","volume":"75","author":"AF Turcu","year":"2020","unstructured":"A.F. Turcu, T. Wannachalee, A. Tsodikov et al., Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping. Hypertension 75, 183\u2013192 (2020). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13866.","journal-title":"Hypertension"},{"key":"4311_CR23","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1096\/fj.03-0935fje","volume":"18","author":"M Darash-Yahana","year":"2004","unstructured":"M. Darash-Yahana, E. Pikarsky, R. Abramovitch et al., Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J. 18, 1240\u20131242 (2004). https:\/\/doi.org\/10.1096\/fj.03-0935fje.","journal-title":"FASEB J."},{"key":"4311_CR24","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"J. Ding, Y. Zhang, J. Wen et al., Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur. J. Nucl. Med. Mol. Imaging 47, 2656\u20132665 (2020). https:\/\/doi.org\/10.1007\/s00259-020-04722-0.","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4311_CR25","doi-asserted-by":"publisher","unstructured":"X. Zhang, Y. Song, Y. Jing et al. Comparison of different diagnostic criteria of 68Ga-Pentixafor PET\/CT for the classification of primary aldosteronism. J. Clin. Endocrinol. Metab. (2024). https:\/\/doi.org\/10.1210\/clinem\/dgae747","DOI":"10.1210\/clinem\/dgae747"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04311-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04311-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04311-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T11:11:47Z","timestamp":1755774707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04311-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["4311"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04311-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethical committee of The Second Affiliated Hospital, Zhejiang University School of Medicine (No. 2025-0149), and the participant gave written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval"}}]}}